Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 September 2020 | Story Nonsindiso Qwabe | Photo Supplied
Women
Carol Bouwer and Prof Puleng LenkaBula believe that the nation is constantly diverting to other issues that take the focus away from amplifying voices for the protection of women and children, hence no real change has taken place. Photo: Supplied

The intersectionality between politics, feminism, and social justice was unpacked extensively in the Student Affairs Women’s Month Webinar that took place on 25 August 2020. This was the second in a series initiated by the Qwaqwa Campus Student Affairs. Director of Student Affairs, Nicole Morris, said the webinars were initiated to encourage difficult conversations around womanhood in South Africa.

UFS Vice-Rector Institutional Change, Student Affairs, and Engaged Scholarship, Prof Puleng LenkaBula, and renowned businesswoman and media mogul, Carol Bouwer, were featured in the second instalment. Together they unpacked the dynamics of being a woman in modern-day South Africa in the face of the scourge of violence against women and children, as well as the transformation and greater representation of women in both positions and institutions of power.

 

Challenge the systems

Setting the tone, Prof LenkaBula said society as a collective needed to come together to challenge systems that oppress, mute, silence, and make it impossible for women to become dignified and contribute fully to the society we live in.

 “If we are to promote social justice, feminism, ethics, and gendered analysis, we have to ensure that we constantly challenge, rethink, and think again around issues that we feel are withholding women from being fully themselves.”

 Bouwer and Prof LenkaBula said the nation is constantly diverted to other issues that are shifting the focus from amplifying voices for the protection of women and children, hence no real change has taken place.

 “As someone who began working during the birth of our freedom in 1994, I think back to the elation that we felt at the creation of the constitution. There was so much jubilation about it, but we exported that excitement to the world and talked about what we had attained without practising it here.”

 “We continue to create systems and amazing documents as a nation, yet we do not implement the very things that will lead to a point where discussions such as these do not need to take place,” Bouwer said.

 Bouwer said the COVID-19 pandemic showed that South Africa had the necessary resources to prioritise gender-based violence, but those in power chose not to.

 “As we speak today, gender-based violence has become a national crisis. We talk about the intersectionality between politics, feminism, and social justice against the confluence of the opposite happening. With what happened when the COVID-19 pandemic was declared a national disaster, we’ve realised that we do have the wherewithal to mobilise for action in this nation, and it is the one thing we have not seen our leaders do,” she said.

 

Part-time feminism will not help

Prof LenkaBula said rethinking feminism was needed to move away from definitions of anti-manhood in order to promote feminist ideals that would benefit the nation as a whole.

 “As a feminist, I want to promote the idea that feminists are not promoting the defamation or marginalisation of men or stripping them of their dignity. We are saying that as men and women, no matter our gender or sexuality, we can work together to ensure that we all live with dignity, we all are equal, and we all express our talents, and are able to utilise opportunities that are available to us in fair ways.”

 Alluding to this, Bouwer said she hoped to see part-time feminism done away with in the rebuilding of society after the pandemic. “Coming out of this pandemic, may our feminism be transformed by everything that is currently happening. There is a huge injection of pathos happening right now and I hope that it is not a fad like everything else that has happened in South Africa, but that it becomes something that we really embody as we go back to whatever normal is going to look like,” she said.

 Qwaqwa Campus SRC Secretary General, Nelisiwe Masango, said the Division of Student Affairs planned the Women’s Month Webinars to discuss topics on issues that affect women directly.

 “These programmes are quite insightful and uplifting. They especially encourage young women to see that the revolution is there, it is real, and it is practical. It gives meaning to continue advocating for better and safe spaces for women. Many times, spaces of contestation are male dominated and therefore women have to be empowered to contest these spaces. These engagements must be ongoing or continuous so that we all understand the issues we are affected by and advocate for a better society.”

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept